SCHEDULE: Vanguard Group Reports Zero P&G Beneficial Ownership

The Vanguard Group, Inc. filed an amended Schedule 13G, reporting 0% beneficial ownership of Procter & Gamble Co/The common stock following an internal realignment.

Summary

• The Vanguard Group, Inc. filed an Amendment No. 12 to its Schedule 13G for Procter & Gamble Co/The.
• The filing reports 0 shares beneficially owned, representing 0% of the class of common stock.
• This change is due to an internal realignment at The Vanguard Group, Inc. on January 12, 2026.
• Following the realignment, certain subsidiaries and business divisions now report beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities held by these disaggregated entities.
• The filing confirms that the securities were acquired and held in the ordinary course of business and not for influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing. It clarifies beneficial ownership reporting due to an internal realignment at Vanguard and does not reflect a change in investment strategy or performance for Procter & Gamble.

Positives

• The filing clarifies the beneficial ownership structure of The Vanguard Group, Inc. following an internal realignment.
• The reporting person certifies that the securities were acquired and held in the ordinary course of business, not for control purposes.

Future Outlook

This administrative filing does not contain forward-looking statements or guidance regarding future performance or investment strategies, as it primarily reports a change in beneficial ownership structure due to an internal realignment.

Management Comments

• The Vanguard Group, Inc. went through an internal realignment on January 12, 2026.
• Certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc. will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on SEC Release No. 34-39538.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that this filing reflects an internal organizational change within The Vanguard Group, a major institutional investor, rather than a change in its overall investment thesis regarding Procter & Gamble. Such realignments are common among large asset managers to optimize reporting structures or comply with regulatory interpretations, and do not necessarily indicate a shift in investment strategy for the underlying holdings, which are now reported by disaggregated entities.

Comparison to Industry Standards

• This filing is an administrative update reflecting an internal organizational change at The Vanguard Group, not a performance-related announcement for Procter & Gamble.
• It aligns with standard regulatory practices for large asset managers to adjust reporting in response to internal restructuring or SEC guidance, such as SEC Release No. 34-39538.
• There are no comparable companies or projects mentioned in the filing to assess against industry standards for performance.

Stakeholder Impact

• Shareholders (Procter & Gamble): No direct impact on P&G's operations or financial performance. The change is administrative for a major institutional investor.
• Shareholders (Vanguard Funds): No direct impact on the underlying investments held by Vanguard funds, as the securities are now reported by disaggregated entities.

Next Steps

• Subsidiaries and/or business divisions of The Vanguard Group, Inc. will report their beneficial ownership separately.

Key Dates

Keywords

Vanguard Group, Procter & Gamble, Schedule 13G, Beneficial Ownership, SEC Filing, Institutional Investor, Common Stock, Realignment